Sæmundur Rögnvaldsson

Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies

Sæmundur Rögnvaldsson, Þorvarður Jón Löve, Sigrún Þorsteinsdóttir et al. · Blood Cancer Journal · 2021 · 109 citations · Full text

Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study

Þórir Einarsson Long, Ólafur S. Indridason, Runólfur Pálsson et al. · Blood Cancer Journal · 2022 · 107 citations · Full text

Prevalence of smoldering multiple myeloma based on nationwide screening

Sigrún Þorsteinsdóttir, Gauti Kjartan Gíslason, Thor Aspelund et al. · Nature Medicine · 2023 · 73 citations · Full text

Hematological Malignancy, Oncology, Cancer Screening +3

Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohorts: results from the population-based iStopMM study

Aðalbjörg Ýr Sigurbergsdóttir, Sæmundur Rögnvaldsson, Sigrún Þorsteinsdóttir et al. · Haematologica · 2023 · 34 citations · Full text

Disease Progression, Genetic Epidemiology, Diagnosis +21

Revised Definition of Free Light Chains in Serum and Light Chain Monoclonal Gammopathy of Undetermined Significance: Results of the Istopmm Study

Þórir Einarsson Long, Sæmundur Rögnvaldsson, Sigrún Þorsteinsdóttir et al. · Blood · 2023 · 20 citations